Genomics, Molecular Pathology, and Pathology of Esophageal and Gastric Cancer
Vieth M, Schneider-Fuchs A, Jankowski JA, Schumacher J (2024)
Publication Type: Book chapter / Article in edited volumes
Publication year: 2024
Publisher: wiley
Edited Volumes: Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e
ISBN: 9781119756422
DOI: 10.1002/9781119756422.ch2
Abstract
Almost 10% of all cancer cases are detected in the stomach and/or esophagus. Unfortunately, survival rates are poor. The molecular background is complex and differs individually. This hampers therapeutic targetting based on mutational analyses. On the other hand a lot is known about molecular subtypes in upper GI-tract cancer. It is even possible to differentiate several subtypes of gastric cancer easily by mutational analysis. Some potential molecular events and target pathways are dicussed. Also, histological criteria how to diangose upper GI-tract neoplasia are shown and explained in detail.[Aspects of environmental risk factors are covered in Chapter Unavailable ].[Aspects of relevant colorectal data are covered in Chapter Unavailable ].
Authors with CRIS profile
Michael Vieth
Professur für Allgemeine Pathologie am Medizincampus Oberfranken
Anna Schneider-Fuchs
Institut für Lehre und Forschung am Medizincampus Oberfranken
Involved external institutions
United Kingdom (GB)
Germany (DE)How to cite
APA:
Vieth, M., Schneider-Fuchs, A., Jankowski, J.A., & Schumacher, J. (2024). Genomics, Molecular Pathology, and Pathology of Esophageal and Gastric Cancer. In Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. wiley.
MLA:
Vieth, Michael, et al. "Genomics, Molecular Pathology, and Pathology of Esophageal and Gastric Cancer." Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. wiley, 2024.
BibTeX: Download